Back to search
FDAFDA · Food and drugs·Recall number Z-2746-2026

ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204

Published July 22, 2026 · Recall initiated: June 12, 2026

Summary

FDA records medical device Class II recall Z-2746-2026, published July 22, 2026 and initiated June 12, 2026. Recalling firm: Tosoh Bioscience Inc; Status: Ongoing; Reported quantity: 310 units; Lot: UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Tosoh Bioscience Inc
Distributor
Global Distribution. US Nationwide.
Lot
UDI-DI: 14560189210032; Lot Numbers: FX12404, FY12407, FY12406, FZ12408
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ST AIA-Pack Testosterone, IN VITRO DIAGNOSTIC USE ONLY for the quantitative measurement of testosterone in human serum on specific Tosoh AIA System analyzers, Model Number 0025204 recalled?

Yes. FDA published recall Z-2746-2026 on July 22, 2026. Reported hazard: The Test cup lot F level 1 low-quality control results values for the device were lower than expected on the Automated Immunoassay Analyzer (AIA) which could cause falsely elevated or falsely low total testosterone results. Such erroneous test results may lead to additional testing/diagnostic interventions and in limited cases, may lead to a delay in diagnosis and/or initiation of unnecessary or incorrect clinical treatment measures.

What should I do if I have this product?

Voluntary: Firm initiated · Letter